SCHEMBL15203003

SCHEMBL15203003

Cc1nccn1CC(=O)NI

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.50
TDP1 Q9NUW8 2/20 0.50
POLB P06746 3/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
GAA P10253 1/20 0.49
MAPT P10636 1/20 0.49
RECQL P46063 1/20 0.49
ALPL P05186 2/20 0.49
ALPG P10696 2/20 0.49
ALPI P09923 1/20 0.49
PLAA Q9Y263 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.48
KMT2A Q03164 3/20 0.48
GFER P55789 1/20 0.48
NOS1 P29475 1/20 0.47
MEN1 O00255 1/20 0.46
GLA P06280 1/20 0.44
FDPS P14324 1/20 0.44
ALDH1A1 P00352 2/20 0.44
GSK3B P49841 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12693214 0.84 KDM4E (0.51) KDM4ETDP1POLBL3MBTL1GAA
SCHEMBL315751 0.83 KDM4E (0.50) KDM4ETDP1POLBL3MBTL1GAA
SCHEMBL15950980 0.79 GRIN2B (0.50) KDM4ETDP1POLBL3MBTL1GAA
SCHEMBL12735399 0.78 ALPL (0.54) KDM4ETDP1POLBL3MBTL1GAA
SCHEMBL369240 0.78 ALPL (0.54) KDM4ETDP1POLBL3MBTL1GAA
SCHEMBL2960305 0.77 ALPL (0.50) KDM4ETDP1POLBL3MBTL1GAA
SCHEMBL1179644 0.77 ALPL (0.53) KDM4ETDP1POLBL3MBTL1GAA
SCHEMBL28938190 0.77 ALPL (0.53) KDM4ETDP1POLBL3MBTL1GAA
Hydrochloric Acid SCHEMBL28835895 0.77 ALPL (0.55) KDM4ETDP1POLBL3MBTL1GAA
SCHEMBL11173573 0.75 SMN1; SMN2 (0.54) KDM4ETDP1POLBL3MBTL1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013120559-A1 USE OF ACYLHYDRAZONES AND THE PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF FOR PREVENTING THE DEVELOPMENT OF RESISTANCE OR REVERSING THE RESISTANCE OF TUMOURS TO CYTOSTATIC DRUGS Ernst-Moritz-Arndt-Universität Greifswald (DE) 2013-08-22 WO disclosed